Kate Haviland, CEO: Blueprint Medicines BPMC Sell · Filed 25/01/23

Trade details

Type: Insider sale
Amount: $159,407.04
Shares · price: 1,446 sh · $110.24 a share
Held after: 149,378 sh
Stock: Blueprint Medicines BPMC
Person: Kate HavilandCEO
Trade date: 25/01/21
Filed: 25/01/23
Days to filing: 2 days

Sold 1.0% of holdings

Share of holding sold: 1.0%

Blueprint Medicines trades, last 26 weeks

What else happened in Blueprint Medicines around then

Filed or reported within 30 days of the trade day · 24/12/22~25/02/20

Kate Haviland's recent trades

Kate HavilandCEO
Sell10b5-1 planBlueprint Medicines
Sell10b5-1 plan
Blueprint Medicines
BPMC
$104.8K
1,200 sh
$104.8K
Filed 25/04/03
Traded 25/04/01
Kate HavilandCEO
Sell10b5-1 planBlueprint Medicines
Sell10b5-1 plan
Blueprint Medicines
BPMC
$51.5K
598 sh
$51.5K
Filed 25/04/03
Traded 25/04/01
Kate HavilandCEO
Sell10b5-1 planBlueprint Medicines
Sell10b5-1 plan
Blueprint Medicines
BPMC
$51.3K
600 sh
$51.3K
Filed 25/04/03
Traded 25/04/01
Kate HavilandCEO
Sell10b5-1 planBlueprint Medicines
Sell10b5-1 plan
Blueprint Medicines
BPMC
$8,859
100 sh
$8,859
Filed 25/04/03
Traded 25/04/01
Kate HavilandCEO
SellBlueprint Medicines
Sell
Blueprint Medicines
BPMC
$1.4M
16,151 sh
$1.4M
Filed 25/03/07
Traded 25/03/05